DNase I hypersensitivity and cryptic promoter activity, together with the connections between TOP2B and transcription led us to suggest that DSBs introduced by TOP2B during transcription (and stabilized by a TOP2 poison) are the causative DSBs in chromosomal translocations in therapy related leukemia with anti-TOP2 drugs [66]. Here, TOP2B is linked to leukemia.